Cargando…
Affinity improvement of the fully human anti-TSLP recombinant antibody
Thymic stromal lymphopoietin (TSLP) is a potentially important target for the treatment of asthma and malignancies. However, a fully human antibody reactive with TSLP is currently unavailable for clinical use. In a previous study, a human anti-TSLP-single-chain antibody variable fragment (anti-TSLP-...
Autores principales: | Chen, Qi, Xian, Dequn, Xu, Wenfeng, Nian, Siji, Yu, Hong, Wu, Yuchuan, Yuan, Qing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6947841/ https://www.ncbi.nlm.nih.gov/pubmed/31974622 http://dx.doi.org/10.3892/mmr.2019.10880 |
Ejemplares similares
-
Development and identification of fully human scFv-Fcs against Staphylococcus aureus
por: Nian, Siji, et al.
Publicado: (2016) -
Fully human recombinant antibodies against EphA2 from a multi-tumor patient immune library suitable for tumor-targeted therapy
por: Yang, Yaqi, et al.
Publicado: (2021) -
TSLP and TSLP receptors variants are associated with smoking
por: Semlali, Abdelhabib, et al.
Publicado: (2019) -
Genetic Regulation of the Thymic Stromal Lymphopoietin (TSLP)/TSLP Receptor (TSLPR) Gene Expression and Influence of Epistatic Interactions Between IL-33 and the TSLP/TSLPR Axis on Risk of Coronary Artery Disease
por: Nie, Shao-Fang, et al.
Publicado: (2018) -
Inhaled anti-TSLP antibody fragment, ecleralimab, blocks responses to allergen in mild asthma
por: Gauvreau, Gail M., et al.
Publicado: (2023)